US Broker Ratings

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A Biotech Powerhouse with a 44.73% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is capturing investor attention with its robust pipeline and an impressive potential upside of 44.73%. Specializing in the development of RNA..

Viking Therapeutics (VKTX) Stock Analysis: Exploring a Potential 251.60% Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) stands out as a compelling opportunity in the biotechnology sector, part of the larger healthcare ecosystem. As a clinical-stage biopharmaceutical company..

Alvotech (ALVO) Stock Analysis: Exploring a 118% Potential Upside in the Biosimilars Market

Alvotech (NASDAQ: ALVO) is attracting significant attention from investors, thanks to its ambitious biosimilar product pipeline and the potential for a substantial stock price appreciation. With..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 17.15% Potential Upside with Strong Buy Ratings

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is capturing investor attention with its innovative approach..

IDEAYA Biosciences, Inc. (IDYA) Investor Outlook: Analyzing an 81.55% Potential Upside in Biotechnology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine in the biotechnology sector, offering a compelling investment opportunity with a potential upside of..

CG Oncology, Inc. (CGON) Stock Analysis: A 70.82% Upside Potential in the Biotech Sector

Investors looking to capitalize on the healthcare sector’s dynamic potential should turn their attention to CG Oncology, Inc. (NASDAQ: CGON), a promising player in the biotechnology..

Bausch Health Companies Inc. (BHC) Stock Analysis: Evaluating Growth Potential with an Enticing Upside

Bausch Health Companies Inc. (NYSE: BHC), a major player in the healthcare sector, operates as a diversified specialty pharmaceutical and medical device company. With its headquarters..

Certara, Inc. (CERT) Stock Analysis: 20.92% Potential Upside in Health Information Services

Certara, Inc. (CERT), a key player in the healthcare sector, specifically within health information services, has caught the attention of individual investors seeking opportunities in technologically-driven..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 64.58% Potential Upside Amidst Solid Dividend Yield

Perrigo Company plc (NASDAQ: PRGO), a stalwart in the healthcare sector, is turning heads with its notable potential upside of 64.58%, making it a compelling consideration..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Promising 23.59% Potential Upside Attracts Investor Interest

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the healthcare sector, stands out in the biotechnology industry with its focus on central nervous system (CNS)..

Galapagos NV (GLPG) Stock Analysis: Navigating Uncharted Biotech Waters Amidst a -23% Potential Downside

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is at a crossroads as it navigates the challenging waters of the healthcare sector. With a current market..

Haemonetics Corporation (HAE) Stock Analysis: Uncovering a 53.65% Potential Upside Amid Healthcare Innovation

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, specializes in medical devices and technologies crucial for modern hospital operations. With a market capitalization..

GeneDx Holdings Corp. (WGS) Stock Analysis: Decoding Growth Potential in the Genomics Sector

GeneDx Holdings Corp. (WGS), a pivotal player in the healthcare sector, stands at the forefront of the diagnostics and research industry. With a market capitalization of..

Ascentage Pharma Group Internat (AAPG): Analyst Ratings Indicate a Promising Future in Biotechnology

Ascentage Pharma Group International (AAPG), a prominent player in the biotechnology sector, is attracting attention with its innovative approach to treating some of the most challenging..

Concentra Group Holdings Parent (CON) Stock Analysis: A Robust 34.76% Upside Potential in the Healthcare Sector

Concentra Group Holdings Parent, Inc. (CON), a formidable player in the healthcare sector, has emerged as a compelling prospect for investors. Specializing in occupational health services,..

Envista Holdings Corporation (NVST) Stock Analysis: A Healthcare Innovator with a Modest Upside

Envista Holdings Corporation (NYSE: NVST), a notable player in the healthcare sector, specializes in the development and distribution of dental products, offering a diverse range of..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Unveiling a 56.19% Potential Upside in the Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands out as a compelling investment opportunity in the biotechnology industry, particularly for investors seeking exposure to the healthcare sector...

Organon & Co. (OGN) Stock Analysis: Exploring a 24.57% Potential Upside in the Healthcare Sector

As a key player in the healthcare sector, Organon & Co. (NYSE: OGN) presents a compelling narrative for investors who are keen on exploring opportunities within..

NovoCure Limited (NVCR) Stock Analysis: Unpacking a Potential 107.70% Upside in the Innovative Oncology Device Sector

NovoCure Limited (NASDAQ: NVCR) is a standout player in the healthcare sector, particularly within the medical devices industry. Known for its pioneering work in oncology, NovoCure..

Ardent Health, Inc. (ARDT) Stock Analysis: A Strong Buy with 46% Potential Upside

Ardent Health, Inc. (ARDT) is making waves in the healthcare sector, particularly within the medical care facilities industry in the United States. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds